Discover open access scientific publications

Search, annotate, share and cite publications

Publications in Respiratory Medicine

OA07.03 Addition of Local Therapy to EGFR TKI Showed Survival Benefit in EGFR-Mutant NSCLC PTS With Oligometastatic or Oligoprogressive Liver Metastases

Journal of Thoracic Oncology

English

P1.13-26 First-Line Continual EGFR-TKI Plus LAT Demonstrated Survival Benefit in Egfr-Mutant NSCLC Patients With Oligoprogressive Disease

Journal of Thoracic Oncology

English

P3.15-14 Using Creative Co-Production to Develop a Treatment Decision Support Tool for People With Malignant Pleural Effusion

Journal of Thoracic Oncology

English

MA26.06 Crizotinib-Treated ALK Immunopositive Metastasized NSCLC Is Associated With an Unfavorable Prognosis When FISH Negative

Journal of Thoracic Oncology

English

P3.11-15 Lung Cancer Symptom Perception and Intervention Preferences in the UK’s Most Deprived Communities: A Qualitative Study

Journal of Thoracic Oncology

English

MA07.06 Telephonic Communication in Palliative Care for Better Management of Terminal Cancer Patients in Rural India - An NGO Based Approach.

Journal of Thoracic Oncology

English

P3.16-19 Clinical Outcomes of Stereotactic Body Radiation Therapy for T2N0M0 Non-Small Cell Lung Cancer

Journal of Thoracic Oncology

English

P2.03-32 Genome-Wide Analysis of M6A-Modified RNA Binding Proteins Associated With Lung Cancer Survival

Journal of Thoracic Oncology

English

P1.15-25 Has Lung Cancer Radiotherapy Utilisation Changed Over Time in New South Wales, Australia?

Journal of Thoracic Oncology

English

P2.13-29 IL-22 Confers Resistance to EGFR-TKIs in Non-Small Cell Lung Cancer Bearing EGFR Gene Mutation and Amplification

Journal of Thoracic Oncology

English

Amanote Research

Discover open access scientific publications

Search, annotate, share and cite publications

Publications in Respiratory Medicine

OA07.03 Addition of Local Therapy to EGFR TKI Showed Survival Benefit in EGFR-Mutant NSCLC PTS With Oligometastatic or Oligoprogressive Liver Metastases

P1.13-26 First-Line Continual EGFR-TKI Plus LAT Demonstrated Survival Benefit in Egfr-Mutant NSCLC Patients With Oligoprogressive Disease

P3.15-14 Using Creative Co-Production to Develop a Treatment Decision Support Tool for People With Malignant Pleural Effusion

MA26.06 Crizotinib-Treated ALK Immunopositive Metastasized NSCLC Is Associated With an Unfavorable Prognosis When FISH Negative

P3.11-15 Lung Cancer Symptom Perception and Intervention Preferences in the UK’s Most Deprived Communities: A Qualitative Study

MA07.06 Telephonic Communication in Palliative Care for Better Management of Terminal Cancer Patients in Rural India - An NGO Based Approach.

P3.16-19 Clinical Outcomes of Stereotactic Body Radiation Therapy for T2N0M0 Non-Small Cell Lung Cancer

P2.03-32 Genome-Wide Analysis of M6A-Modified RNA Binding Proteins Associated With Lung Cancer Survival

P1.15-25 Has Lung Cancer Radiotherapy Utilisation Changed Over Time in New South Wales, Australia?

P2.13-29 IL-22 Confers Resistance to EGFR-TKIs in Non-Small Cell Lung Cancer Bearing EGFR Gene Mutation and Amplification